Buloxibutid | m-entrepreneurship.com

Product Name :
Buloxibutid

Search keywords :
Buloxibutid

drugId :
null

Target Vo:
Angiotensin II receptor type 2

Target Vo Short Name :
AT2

Moa_Name:
Angiotensin II receptor type 2 agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Vicore Pharma

Active Company_Name :
Nippon Shinyaku Co Ltd

Active Indication_Name:
Coronavirus Disease 2019 (COVID-19)

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FGFR1 Antibody
Bim Antibody
Villin Antibody: Villin Antibody is an unconjugated, rabbit-derived, anti-Villin monoclonal antibody. Villin Antibody can be used for: WB, IHC-P, IP expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts